Far Out: This is Why Psychedelics are the Next Big Thing for Investors
Wed March 18, 2020
Houston Texas--(Newsfile Corp. - March 18, 2020) - Psychedelics are the next big thing for investors.
In fact, as they show further proof of effectiveness in the treatment of depression, ADHD, anxiety, addiction, and neurological disorders, multi-billion-dollar pharmaceutical companies are likely to invest in it, and develop new treatments.
"Based on the studies currently underway, psychedelics and psychedelic-assisted psychotherapy are promising new paradigms for the treatment of neuropsychiatric disorders," says Dr. Michael Ehlers, an advisor to Field Trip Psychedelics, as quoted by Forbes. "Some studies are showing that psychedelic-assisted psychotherapy using psilocybin and MDMA to treat depression and PTSD are helping patients manage symptoms of these conditions. In some instances, these treatments are leading to remission of the condition itself."
Major institutions are studying psychedelics such as magic mushrooms such as Johns Hopkins, New York University, the University of California Los Angeles, and Emory University. Plus, "These studies are already operating with approval from and under the watchful eye of the feds, but legalization would allow experts to do things like, say, put their findings to use in therapeutic settings," adds Boston Magazine.
And, as explained by Business Insider, such drugs have the power of "Extracting the patient from his or her usual patterns of thought," which in turn allows them to contemplate "them from a vantage point."
The best part -- if psychedelics, like mushrooms, continue to prove effective in the treatment of depression, ADHD, anxiety, addiction, and neurological disorders, pharmaceutical companies could jump on the opportunity, as well. Traditional pharmaceutical companies already earn billions to manufacture other drugs for such ailments.
Sweeping Legalization Throughout the U.S.
Over the last year alone, Denver, Oakland, and Santa Cruz voted to decriminalize mushrooms. Washington, D.C. just took a major step toward adding legalization to the Nov. 2020 ballot.
Chicago city leaders just passed a resolution supporting scientific and medicinal research, with a goal of decriminalization. In fact, citing a 1979 study, the resolution defines entheogenic substances as any range of natural plants or fungi "that can inspire personal and spiritual well-being," as well as other psychological and physical benefits, as noted by Illinois Policy.
Vermont lawmakers filed a bill to decriminalize it, as well. "Plants, especially plant medicines, should be accessible to people," said Rep. Brian Cina, as quoted by Marijuana Movement. "Use of plant medicine should be considered a health care issue, not a criminal issue."
Yield Growth (BOSQF) is making substantial moves into psilocybin mushrooms.
Just recently, Yield Growth developed Ayurvedic mushroom coffees and Ayurvedic mushroom botanical shots for smoothies. In fact, its Ayurvedic coffees and botanical shots are planned for launch in early summer of 2020 and contain immune-boosting medicinal mushrooms: reishi, chaga, lion's mane and turkey tail.
"These formulations provide powerful brain and immune-boosting benefits thanks to their powerful antioxidant and nutrient-rich formulas," said Penny White, CEO of The Yield Growth Corp. "Along with their powerful health profile, these products are made with fair-trade, organic ingredients."
Chaga mushrooms have been used for centuries in Siberia and Asia as medicine to reduce inflammation, boost immunity and improve overall health. Chaga also has the ability to lower high blood sugar and combat abnormal and mutagenic cell growth.
Turkey Tail also contains a community of powerful antioxidants and other compounds that may help boost your immune system and may even fight certain cancers. Some scientific studies have also shown that Turkey Tail may also improve gut bacteria balance.
Reishi is one of the most popular medicinal mushrooms and is known to be used to assist in weight loss, boost immunity and fight certain cancer cells. What makes it unique though are its calming properties thanks to a compound called triterpene that it contains. This can help to promote healing, sharpen focus, alleviate anxiety, ease depression, and encourage better sleep.
Lion's Mane is also packed with antioxidants and also strengthens the immune system, but it also has other unique benefits that foster mental clarity and brain health. For example, it aids in the production of the bioprotein nerve growth factor (NFG) and myelin, which acts as "insulation" around nerve fibers and helps to fight the onset of neurological diseases such as Alzheimer's and multiple sclerosis.
However, that's just part of Yield Growth's story.
Flourish Mushroom Labs Inc. also announced it acquired technology rights from its parent company The Yield Growth Corp. and filed a U.S. provisional patent for the invention of a method of manufacture for a mushroom extract that may be used in a variety of therapeutic and pharmaceutical formulations.
The patent application covers the invention of a unique mushroom extract which may have unique medicinal properties, as well as a method of manufacturing the extract from mushrooms including Psilocybe mexicana, and formulations and emulsions containing the mushroom extract. The mushroom extract may be in the form of an aqueous solution, or it may be a freeze or spray dried powder.
"Our proprietary extraction technology was initially invented to extract compounds from the root of the cannabis plant to manufacture hemp root oil, which we use in a number of our products, including our Urban Juve skincare line," said Penny White, CEO of The Yield Growth Corp. and Flourish Mushroom Labs. "There is now also great interest in using this technology for medicinal mushrooms and psychedelic mushrooms when and where they are legal."
For more information, visit the company's website at https://yieldgrowth.com.
https://seekingalpha.com/pr/17812409-far-out-...-investors
Wed March 18, 2020
Houston Texas--(Newsfile Corp. - March 18, 2020) - Psychedelics are the next big thing for investors.
In fact, as they show further proof of effectiveness in the treatment of depression, ADHD, anxiety, addiction, and neurological disorders, multi-billion-dollar pharmaceutical companies are likely to invest in it, and develop new treatments.
"Based on the studies currently underway, psychedelics and psychedelic-assisted psychotherapy are promising new paradigms for the treatment of neuropsychiatric disorders," says Dr. Michael Ehlers, an advisor to Field Trip Psychedelics, as quoted by Forbes. "Some studies are showing that psychedelic-assisted psychotherapy using psilocybin and MDMA to treat depression and PTSD are helping patients manage symptoms of these conditions. In some instances, these treatments are leading to remission of the condition itself."
Major institutions are studying psychedelics such as magic mushrooms such as Johns Hopkins, New York University, the University of California Los Angeles, and Emory University. Plus, "These studies are already operating with approval from and under the watchful eye of the feds, but legalization would allow experts to do things like, say, put their findings to use in therapeutic settings," adds Boston Magazine.
And, as explained by Business Insider, such drugs have the power of "Extracting the patient from his or her usual patterns of thought," which in turn allows them to contemplate "them from a vantage point."
The best part -- if psychedelics, like mushrooms, continue to prove effective in the treatment of depression, ADHD, anxiety, addiction, and neurological disorders, pharmaceutical companies could jump on the opportunity, as well. Traditional pharmaceutical companies already earn billions to manufacture other drugs for such ailments.
Sweeping Legalization Throughout the U.S.
Over the last year alone, Denver, Oakland, and Santa Cruz voted to decriminalize mushrooms. Washington, D.C. just took a major step toward adding legalization to the Nov. 2020 ballot.
Chicago city leaders just passed a resolution supporting scientific and medicinal research, with a goal of decriminalization. In fact, citing a 1979 study, the resolution defines entheogenic substances as any range of natural plants or fungi "that can inspire personal and spiritual well-being," as well as other psychological and physical benefits, as noted by Illinois Policy.
Vermont lawmakers filed a bill to decriminalize it, as well. "Plants, especially plant medicines, should be accessible to people," said Rep. Brian Cina, as quoted by Marijuana Movement. "Use of plant medicine should be considered a health care issue, not a criminal issue."
Yield Growth (BOSQF) is making substantial moves into psilocybin mushrooms.
Just recently, Yield Growth developed Ayurvedic mushroom coffees and Ayurvedic mushroom botanical shots for smoothies. In fact, its Ayurvedic coffees and botanical shots are planned for launch in early summer of 2020 and contain immune-boosting medicinal mushrooms: reishi, chaga, lion's mane and turkey tail.
"These formulations provide powerful brain and immune-boosting benefits thanks to their powerful antioxidant and nutrient-rich formulas," said Penny White, CEO of The Yield Growth Corp. "Along with their powerful health profile, these products are made with fair-trade, organic ingredients."
Chaga mushrooms have been used for centuries in Siberia and Asia as medicine to reduce inflammation, boost immunity and improve overall health. Chaga also has the ability to lower high blood sugar and combat abnormal and mutagenic cell growth.
Turkey Tail also contains a community of powerful antioxidants and other compounds that may help boost your immune system and may even fight certain cancers. Some scientific studies have also shown that Turkey Tail may also improve gut bacteria balance.
Reishi is one of the most popular medicinal mushrooms and is known to be used to assist in weight loss, boost immunity and fight certain cancer cells. What makes it unique though are its calming properties thanks to a compound called triterpene that it contains. This can help to promote healing, sharpen focus, alleviate anxiety, ease depression, and encourage better sleep.
Lion's Mane is also packed with antioxidants and also strengthens the immune system, but it also has other unique benefits that foster mental clarity and brain health. For example, it aids in the production of the bioprotein nerve growth factor (NFG) and myelin, which acts as "insulation" around nerve fibers and helps to fight the onset of neurological diseases such as Alzheimer's and multiple sclerosis.
However, that's just part of Yield Growth's story.
Flourish Mushroom Labs Inc. also announced it acquired technology rights from its parent company The Yield Growth Corp. and filed a U.S. provisional patent for the invention of a method of manufacture for a mushroom extract that may be used in a variety of therapeutic and pharmaceutical formulations.
The patent application covers the invention of a unique mushroom extract which may have unique medicinal properties, as well as a method of manufacturing the extract from mushrooms including Psilocybe mexicana, and formulations and emulsions containing the mushroom extract. The mushroom extract may be in the form of an aqueous solution, or it may be a freeze or spray dried powder.
"Our proprietary extraction technology was initially invented to extract compounds from the root of the cannabis plant to manufacture hemp root oil, which we use in a number of our products, including our Urban Juve skincare line," said Penny White, CEO of The Yield Growth Corp. and Flourish Mushroom Labs. "There is now also great interest in using this technology for medicinal mushrooms and psychedelic mushrooms when and where they are legal."
For more information, visit the company's website at https://yieldgrowth.com.
https://seekingalpha.com/pr/17812409-far-out-...-investors
